Income Statement Gecoss Corporation OTC Markets

Stocks

GCSSF

JP3225500002

Construction Supplies & Fixtures

Market Closed - OTC Markets Other stock markets 12:28:09 2026-05-26 EDT			5-day change	1st Jan Change
9.530 ^USD	+6.12%		-.--%	+6.12%

05-11	Gecoss Corporation Provides Dividend Forecasts for the Second Quarter of Year Ending March 31, 2027 and Year Ending March 31, 2027	CI
05-11	Gecoss Corporation Provides Consolidated Earnings Guidance for the First Half of Fiscal Year Ending March 31, 2027 and Full Year Ending March 31, 2027	CI

078613d0f3beef5f30043a8d65.2SsNKqacxvs_0ELF7nBG4J0u1Gmpqka2zEjuwJA1_4o.nXtke_Sxs5FyshG12C8Mgs9mv0TG4jPOpC3bscJas7yXcmF_1uyWvAe3Ew

Published financial data: GECOSS CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	110B	114B	121B	128B	112B
Total Revenues	110B	114B	121B	128B	112B
Cost of Goods Sold, Total	90.24B	94.98B	101B	106B	88.24B
Gross Profit	19.97B	19.01B	19.74B	22.06B	23.31B
Selling General & Admin Expenses, Total	13.9B	14.31B	15.24B	15.82B	16.46B
Other Operating Expenses, Total	13.9B	14.31B	15.24B	15.82B	16.46B
Operating Income	6.07B	4.71B	4.5B	6.24B	6.85B
Interest Expense, Total	-22M	-18M	-14M	-20M	-17M
Interest And Investment Income	88M	97M	98M	123M	149M
Net Interest Expenses	66M	79M	84M	103M	132M
Income (Loss) On Equity Invest.	239M	286M	282M	187M	-217M
Other Non Operating Income (Expenses)	56M	74M	39M	54M	81M
EBT, Excl. Unusual Items	6.43B	5.14B	4.91B	6.59B	6.85B
Gain (Loss) On Sale Of Investments	-	-	199M	-	-
Gain (Loss) On Sale Of Assets	67M	93M	-5M	14M	-53M
Asset Writedown	-	-467M	-	-	-
Other Unusual Items	-6M	-	-	-195M	-
EBT, Incl. Unusual Items	6.49B	4.77B	5.1B	6.41B	6.79B
Income Tax Expense	1.95B	1.45B	1.67B	1.99B	2.25B
Earnings From Continuing Operations	4.55B	3.32B	3.43B	4.41B	4.54B
Net Income to Company	4.55B	3.32B	3.43B	4.41B	4.54B
Minority Interest	1M	2M	-	-	-
Net Income - (IS)	4.55B	3.33B	3.43B	4.41B	4.54B
Net Income to Common Incl Extra Items	4.55B	3.33B	3.43B	4.41B	4.54B
Net Income to Common Excl. Extra Items	4.55B	3.33B	3.43B	4.41B	4.54B
Per Share Items
Net EPS - Basic	124.98	91.38	95.03	130.61	134.79
Basic EPS - Continuing Operations	124.98	91.38	95.03	130.61	134.79
Basic Weighted Average Shares Outstanding	36.4M	36.4M	36.07M	33.8M	33.7M
Net EPS - Diluted	124.98	91.38	95.03	130.61	134.79
Diluted EPS - Continuing Operations	124.98	91.38	95.03	130.61	134.79
Diluted Weighted Average Shares Outstanding	36.4M	36.4M	36.07M	33.8M	33.7M
Normalized Basic EPS	110.49	88.41	85.04	121.84	126.97
Normalized Diluted EPS	110.49	88.41	85.04	121.84	126.97
Dividend Per Share	35	35	35	40	54
Payout Ratio	27.98	38.3	37.16	28.32	31.92
Supplemental Items
EBITDA	8.87B	7.56B	7.79B	9.65B	10.16B
EBITA	6.07B	4.71B	4.6B	6.37B	6.98B
EBIT	6.07B	4.71B	4.5B	6.24B	6.85B
Effective Tax Rate - (Ratio)	29.97	30.33	32.81	31.11	33.13
Normalized Net Income	4.02B	3.22B	3.07B	4.12B	4.28B
Non-Cash Pension Expense	-317M	-504M	-417M	-315M	-379M
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	62M	45M	43M	40M	29M

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	1.12B	986M	1.27B	1.14B	3.09B
Short Term Investments	5.9B	9.3B	3.5B	-	-
Total Cash And Short Term Investments	7.02B	10.29B	4.77B	1.14B	3.09B
Accounts Receivable, Total	40.16B	41.28B	42.73B	38.78B	36.47B
Total Receivables	40.16B	41.28B	42.73B	38.78B	36.47B
Inventory	23.9B	24.3B	26.09B	28.5B	28.68B
Other Current Assets, Total	367M	253M	307M	310M	370M
Total Current Assets	71.45B	76.13B	73.89B	68.72B	68.61B
Net Property Plant And Equipment	23.44B	23.28B	24.46B	24.6B	24.41B
Long-term Investments	7.29B	7.56B	8.25B	11.6B	12.14B
Goodwill	-	-	1.19B	1.06B	934M
Other Intangibles, Total	672M	786M	1.19B	1.06B	970M
Other Long-Term Assets, Total	0	-	-	-1M	-
Total Assets	103B	108B	109B	107B	107B
Liabilities
Accounts Payable, Total	30.09B	34.71B	35.73B	28.92B	26.4B
Accrued Expenses, Total	1.15B	1.08B	1.11B	1.26B	1.33B
Short-term Borrowings	1.96B	-	520M	1.97B	15M
Current Portion of Leases	5M	-	-	-	-
Current Income Taxes Payable	1.18B	845M	1.16B	1.31B	1.4B
Other Current Liabilities	3.57B	7.03B	6.43B	6.47B	7.19B
Total Current Liabilities	37.96B	43.66B	44.94B	39.92B	36.33B
Long-Term Debt	2.11B	2.11B	1.72B	632M	617M
Long-Term Leases	-	-	-	-	-
Pension & Other Post Retirement Benefits	588M	590M	642M	632M	579M
Deferred Tax Liability Non Current	2.4B	1.95B	2.51B	2.89B	3.17B
Other Non Current Liabilities	-1M	0	60M	52M	89M
Total Liabilities	43.05B	48.32B	49.88B	44.13B	40.79B
Common Stock, Total	4.4B	4.4B	4.4B	4.4B	4.4B
Additional Paid In Capital	4.6B	4.59B	4.59B	4.59B	4.59B
Retained Earnings	49.6B	49.62B	49.46B	52.62B	55.77B
Treasury Stock	-24M	-25M	-	-1M	-142M
Comprehensive Income and Other	1.23B	840M	650M	1.3B	1.66B
Total Common Equity	59.79B	59.43B	59.1B	62.91B	66.28B
Minority Interest	1M	4M	3M	4M	5M
Total Equity	59.79B	59.43B	59.1B	62.92B	66.29B
Total Liabilities And Equity	103B	108B	109B	107B	107B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	36.4M	36.4M	33.8M	33.79M	33.64M
ECS Total Common Shares Outstanding	36.4M	36.4M	33.8M	33.79M	33.64M
Book Value / Share	1.64K	1.63K	1.75K	1.86K	1.97K
Tangible Book Value	59.12B	58.64B	56.72B	60.79B	64.38B
Tangible Book Value Per Share	1.62K	1.61K	1.68K	1.8K	1.91K
Total Debt	4.08B	2.11B	2.24B	2.6B	632M
Net Debt	-2.94B	-8.18B	-2.52B	1.47B	-2.46B
Debt Equivalent of Unfunded Proj. Benefit Obligation	-2.59B	-2.93B	-2.65B	-3.61B	-4.31B
Minority Interest, Total (Incl. Fin. Div)	1M	4M	3M	4M	5M
Inventories - Raw Materials, Total	474M	645M	896M	765M	637M
Inventories - Work In Process, Total	532M	670M	978M	1.26B	985M
Inventories - Finished Goods, Total	22.89B	22.99B	24.21B	26.47B	27.06B
Full Time Employees	1.27K	1.28K	1.36K	1.38K	1.38K
Accumulated Allowance for Doubtful Accounts (Supple)	156M	27M	28M	18M	19M

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	6.49B	4.77B	5.1B	6.41B	6.79B
Depreciation & Amortization - CF	2.8B	2.86B	3.19B	3.28B	3.18B
Amortization of Goodwill and Intangible Assets - (CF)	-	-	97M	129M	129M
Depreciation & Amortization, Total	2.8B	2.86B	3.29B	3.41B	3.31B
(Gain) Loss From Sale Of Asset	-283M	35M	-303M	-531M	-248M
(Gain) Loss on Sale of Investments - (CF)	-	-	-199M	-	-
(Income) Loss On Equity Investments - (CF)	-239M	-286M	-282M	-187M	217M
Other Operating Activities, Total	-1.88B	-882M	-1.01B	-1.6B	-1.88B
Change In Accounts Receivable	-281M	-1.01B	-1.13B	3.96B	2.31B
Change In Inventories	2.22B	801M	-1.8B	-2.44B	-192M
Change In Accounts Payable	-820M	3.87B	434M	-6.6B	-1.92B
Change in Other Net Operating Assets	496M	-1.05B	-1.16B	-356M	396M
Cash from Operations	8.5B	9.1B	2.95B	2.06B	8.78B
Capital Expenditure	-2.38B	-2.78B	-2.6B	-3.08B	-3.33B
Sale of Property, Plant, and Equipment	269M	453M	319M	597M	323M
Cash Acquisitions	-	-	-2.05B	-	-
Sale (Purchase) of Intangible assets	-313M	-276M	-236M	-169M	-146M
Investment in Marketable and Equity Securities, Total	-4M	-4M	196M	-1.64B	-6M
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	-	-	-
Other Investing Activities, Total	-8M	-8M	-376M	-502M	-118M
Cash from Investing	-2.43B	-2.61B	-4.75B	-4.8B	-3.28B
Short Term Debt Issued, Total	-	-	-	800M	-
Long-Term Debt Issued, Total	-	-	-	90M	-
Total Debt Issued	-	-	-	890M	-
Short Term Debt Repaid, Total	-	-	-	-	-800M
Long-Term Debt Repaid, Total	-	-1.96B	-160M	-533M	-1.17B
Total Debt Repaid	-	-1.96B	-160M	-533M	-1.97B
Repurchase of Common Stock	-1M	-	-2.29B	-1M	-141M
Common Dividends Paid	-1.27B	-1.27B	-1.27B	-1.25B	-1.45B
Common & Preferred Stock Dividends Paid	-1.27B	-1.27B	-1.27B	-1.25B	-1.45B
Other Financing Activities, Total	-1M	-	-	-	-2M
Cash from Financing	-1.28B	-3.23B	-3.73B	-894M	-3.56B
Foreign Exchange Rate Adjustments	-4M	16M	7M	-1M	-13M
Miscellaneous Cash Flow Adjustments	-	-	-	-	-
Net Change in Cash	4.79B	3.27B	-5.52B	-3.63B	1.93B
Supplemental Items
Cash Interest Paid	22M	22M	14M	20M	18M
Cash Income Tax Paid (Refund)	2.11B	1.14B	1.16B	1.73B	2.04B
Levered Free Cash Flow	5.27B	8.99B	725M	-880M	4.53B
Unlevered Free Cash Flow	5.28B	9B	733M	-868M	4.54B
Change In Net Working Capital	-1.38B	-6.26B	2.53B	4.93B	-430M
Net Debt Issued / Repaid	-	-1.96B	-160M	357M	-1.97B

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	3.76	2.79	2.6	3.61	4
Return on Total Capital	6.13	4.69	4.58	6.15	6.47
Return On Equity %	7.87	5.58	5.78	7.23	7.03
Return on Common Equity	7.87	5.58	5.78	7.24	7.03
Margin Analysis
Gross Profit Margin %	18.12	16.68	16.38	17.21	20.9
SG&A Margin	12.61	12.55	12.64	12.34	14.75
EBITDA Margin %	8.05	6.63	6.47	7.53	9.11
EBITA Margin %	5.51	4.13	3.82	4.97	6.26
EBIT Margin %	5.51	4.13	3.74	4.87	6.14
Income From Continuing Operations Margin %	4.13	2.92	2.84	3.44	4.07
Net Income Margin %	4.13	2.92	2.84	3.44	4.07
Net Avail. For Common Margin %	4.13	2.92	2.84	3.44	4.07
Normalized Net Income Margin	3.65	2.82	2.55	3.21	3.84
Levered Free Cash Flow Margin	4.78	7.89	0.6	-0.69	4.06
Unlevered Free Cash Flow Margin	4.8	7.9	0.61	-0.68	4.07
Asset Turnover
Asset Turnover	1.09	1.08	1.11	1.19	1.04
Fixed Assets Turnover	4.67	4.88	5.05	5.23	4.55
Receivables Turnover (Average Receivables)	2.75	2.8	2.87	3.15	2.96
Inventory Turnover (Average Inventory)	3.61	3.94	4	3.89	3.09
Short Term Liquidity
Current Ratio	1.88	1.74	1.64	1.72	1.89
Quick Ratio	1.24	1.18	1.06	1	1.09
Operating Cash Flow to Current Liabilities	0.22	0.21	0.07	0.05	0.24
Days Sales Outstanding (Average Receivables)	132.5	130.39	127.22	116.36	123.11
Days Outstanding Inventory (Average Inventory)	101.22	92.62	91.25	94.12	118.26
Average Days Payable Outstanding	126.84	123.99	125.33	108.99	114.18
Cash Conversion Cycle (Average Days)	106.88	99.02	93.14	101.49	127.19
Long Term Solvency
Total Debt/Equity	6.82	3.55	3.8	4.14	0.95
Total Debt / Total Capital	6.38	3.43	3.66	3.97	0.94
LT Debt/Equity	3.53	3.55	2.92	1	0.93
Long-Term Debt / Total Capital	3.3	3.43	2.81	0.96	0.92
Total Liabilities / Total Assets	41.86	44.84	45.77	41.22	38.09
EBIT / Interest Expense	276	261.44	321.64	312.2	403
EBITDA / Interest Expense	403.23	420.11	556.64	482.6	597.47
(EBITDA - Capex) / Interest Expense	295.23	265.94	370.64	328.6	401.47
Total Debt / EBITDA	0.46	0.28	0.29	0.27	0.06
Net Debt / EBITDA	-0.33	-1.08	-0.32	0.15	-0.24
Total Debt / (EBITDA - Capex)	0.63	0.44	0.43	0.4	0.09
Net Debt / (EBITDA - Capex)	-0.45	-1.71	-0.49	0.22	-0.36
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-3.6	3.44	5.72	6.37	-12.98
Gross Profit, 1 Yr. Growth %	-1.69	-4.78	3.82	11.78	5.64
EBITDA, 1 Yr. Growth %	-2.34	-14.76	3.05	23.85	5.23
EBITA, 1 Yr. Growth %	-3.86	-22.5	-2.25	38.54	9.52
EBIT, 1 Yr. Growth %	-3.86	-22.5	-4.31	38.66	9.72
Earnings From Cont. Operations, 1 Yr. Growth %	3.25	-26.91	3.13	28.76	2.92
Net Income, 1 Yr. Growth %	3.25	-26.89	3.07	28.76	2.92
Normalized Net Income, 1 Yr. Growth %	-4.58	-19.99	-4.67	34.23	3.93
Diluted EPS Before Extra, 1 Yr. Growth %	3.25	-26.88	4	37.43	3.2
Accounts Receivable, 1 Yr. Growth %	0.78	2.79	3.5	-9.24	-5.95
Inventory, 1 Yr. Growth %	-8.61	1.7	7.34	9.24	0.63
Net Property, Plant and Equip., 1 Yr. Growth %	-1.37	-0.68	5.07	0.55	-0.74
Total Assets, 1 Yr. Growth %	4.01	4.77	1.14	-1.78	0.03
Tangible Book Value, 1 Yr. Growth %	7.18	-0.81	-3.28	7.18	5.9
Common Equity, 1 Yr. Growth %	7.18	-0.61	-0.55	6.45	5.35
Cash From Operations, 1 Yr. Growth %	-24.84	6.97	-67.55	-30.15	325.85
Capital Expenditures, 1 Yr. Growth %	-38.59	16.79	-6.16	18.28	8.18
Levered Free Cash Flow, 1 Yr. Growth %	-23.53	70.6	-91.94	-221.44	-614.69
Unlevered Free Cash Flow, 1 Yr. Growth %	-23.58	70.37	-91.86	-218.29	-623.33
Dividend Per Share, 1 Yr. Growth %	0	0	0	14.29	35
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	0.84	-0.14	4.58	6.04	-3.79
Gross Profit, 2 Yr. CAGR %	1.87	-3.25	-0.57	7.73	8.67
EBITDA, 2 Yr. CAGR %	2.36	-8.76	-6.27	12.98	14.16
EBITA, 2 Yr. CAGR %	0.52	-13.68	-12.96	16.37	23.18
EBIT, 2 Yr. CAGR %	0.52	-13.68	-13.88	15.19	23.35
Earnings From Cont. Operations, 2 Yr. CAGR %	2.24	-13.13	-13.18	15.24	15.12
Net Income, 2 Yr. CAGR %	2.24	-13.12	-13.19	15.2	15.12
Normalized Net Income, 2 Yr. CAGR %	-0.09	-12.63	-12.66	13.12	18.11
Diluted EPS Before Extra, 2 Yr. CAGR %	2.24	-13.12	-12.8	19.55	19.09
Accounts Receivable, 2 Yr. CAGR %	-4.3	1.78	3.15	-3.08	-7.61
Inventory, 2 Yr. CAGR %	-5.87	-3.59	4.48	8.28	4.85
Net Property, Plant and Equip., 2 Yr. CAGR %	1.42	-1.03	2.15	2.79	-0.1
Total Assets, 2 Yr. CAGR %	0.64	4.39	2.94	-0.33	-0.88
Tangible Book Value, 2 Yr. CAGR %	6	3.11	-2.05	1.82	6.54
Common Equity, 2 Yr. CAGR %	6.12	3.21	-0.58	2.89	5.9
Cash From Operations, 2 Yr. CAGR %	160.62	-10.34	-41.08	-52.39	72.47
Capital Expenditures, 2 Yr. CAGR %	-18.33	-15.31	4.69	5.35	13.12
Levered Free Cash Flow, 2 Yr. CAGR %	66.82	14.22	-62.92	-68.72	150.01
Unlevered Free Cash Flow, 2 Yr. CAGR %	68.01	14.11	-62.75	-68.96	148.8
Dividend Per Share, 2 Yr. CAGR %	8.01	0	0	6.9	24.21
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	1.68	1.7	1.77	5.17	-0.72
Gross Profit, 3 Yr. CAGR %	2.73	-0.4	-0.95	3.39	7.03
EBITDA, 3 Yr. CAGR %	4.02	-3.69	-4.98	2.85	10.33
EBITA, 3 Yr. CAGR %	1.27	-7.82	-10.03	1.63	14.04
EBIT, 3 Yr. CAGR %	1.27	-7.82	-10.67	0.94	13.34
Earnings From Cont. Operations, 3 Yr. CAGR %	0.86	-8.58	-8.02	-0.99	10.98
Net Income, 3 Yr. CAGR %	0.86	-8.57	-8.03	-1	10.95
Normalized Net Income, 3 Yr. CAGR %	0.35	-7.22	-10.05	0.79	9.97
Diluted EPS Before Extra, 3 Yr. CAGR %	0.86	-8.57	-7.75	1.48	13.83
Accounts Receivable, 3 Yr. CAGR %	-4	-1.99	2.35	-1.16	-4.05
Inventory, 3 Yr. CAGR %	-0.09	-3.41	-0.08	6.04	5.67
Net Property, Plant and Equip., 3 Yr. CAGR %	3.26	0.71	0.97	1.62	1.6
Total Assets, 3 Yr. CAGR %	0.9	1.99	3.29	1.34	-0.21
Tangible Book Value, 3 Yr. CAGR %	6.02	3.68	0.93	0.93	3.16
Common Equity, 3 Yr. CAGR %	6.12	3.83	1.94	1.71	3.71
Cash From Operations, 3 Yr. CAGR %	-1.55	93.69	-36.1	-37.64	-1.17
Capital Expenditures, 3 Yr. CAGR %	-8.41	-7.99	-12.36	9.04	6.29
Levered Free Cash Flow, 3 Yr. CAGR %	-0.41	68.07	-52.81	-44.94	-20.44
Unlevered Free Cash Flow, 3 Yr. CAGR %	-0.49	68.79	-52.67	-45.25	-20.41
Dividend Per Share, 3 Yr. CAGR %	5.27	5.27	0	4.55	15.55
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	5.07	2.92	2.83	3.42	-0.49
Gross Profit, 5 Yr. CAGR %	1.91	0.88	1.39	2.78	2.79
EBITDA, 5 Yr. CAGR %	0.57	-1.48	-0.23	2.66	2.26
EBITA, 5 Yr. CAGR %	-2.18	-5.44	-4.68	1.18	2.02
EBIT, 5 Yr. CAGR %	-2.18	-5.44	-5.09	0.77	1.64
Earnings From Cont. Operations, 5 Yr. CAGR %	-1.13	-5.86	-5.01	0.29	0.62
Net Income, 5 Yr. CAGR %	-1.13	-5.85	-5.02	0.28	0.61
Normalized Net Income, 5 Yr. CAGR %	-1.77	-4.84	-5.07	0.43	0.3
Diluted EPS Before Extra, 5 Yr. CAGR %	-1.13	-5.84	-4.84	1.78	2.17
Accounts Receivable, 5 Yr. CAGR %	1.68	-2.01	-1.2	-2.43	-1.76
Inventory, 5 Yr. CAGR %	-1.99	-0.04	1.71	1.11	1.86
Net Property, Plant and Equip., 5 Yr. CAGR %	3.19	2.79	2.81	1.54	0.54
Total Assets, 5 Yr. CAGR %	2.34	1.79	1.71	1.06	1.6
Tangible Book Value, 5 Yr. CAGR %	6.79	4.87	2.71	2.93	3.14
Common Equity, 5 Yr. CAGR %	6.83	5.01	3.39	3.45	3.51
Cash From Operations, 5 Yr. CAGR %	5.59	10.28	-19.83	10.49	-4.94
Capital Expenditures, 5 Yr. CAGR %	1.08	7.8	-3.38	-2.87	-2.94
Levered Free Cash Flow, 5 Yr. CAGR %	7.21	21.71	-32.92	-14.22	-8.06
Unlevered Free Cash Flow, 5 Yr. CAGR %	6.8	21.41	-32.83	-14.26	-8.07
Dividend Per Share, 5 Yr. CAGR %	5.33	3.13	3.13	5.92	9.06